Sonoco Products Company Common Stock (SON)

Total Non-Current Assets

$7.33B

Quarterly · Period ending: · USD

SON logo

SON Total Non-Current Assets

Latest reported$7.33B
SON Quarterly Non-Current Assets ($301.30M → $7.33B)
High-resolution chart · PNG

SON total non-current assets history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Sonoco Products Company Common Stock Total Non-Current Assets — Quarterly (USD)
Period endingTotal Non-Current Assets (USD)
7,326,915,000
8,186,725,000
8,327,615,000
8,516,010,000
8,559,745,000
8,933,806,000
9,506,319,000
9,329,230,000
5,073,830,000
5,040,200,999
5,133,676,000
5,141,592,000
5,030,111,000
4,689,112,000
4,699,107,000
4,691,686,000
4,564,326,000
4,613,026,000
4,705,343,000
3,414,558,000
3,324,495,000
3,347,200,000
3,330,011,000
3,446,712,000
3,483,798,000
3,500,198,000
3,498,308,999
3,605,093,000
3,422,154,000
3,366,544,000
3,373,013,000
3,064,193,000
3,008,129,000
3,048,000,000
2,989,033,000
2,994,085,000
2,994,303,000
2,827,766,000
2,799,110,000
2,574,435,000
2,564,342,000
2,693,123,000
2,727,520,000
2,712,891,000
2,710,464,000
2,756,657,000
2,729,319,000
2,819,713,000
2,542,197,000
2,572,539,000
2,575,372,000
2,600,817,000
2,630,008,000
2,625,888,000
2,659,167,000
2,676,169,000
2,677,191,000
2,661,287,000
2,682,044,000
2,673,379,000
2,104,801,000
2,148,188,000
2,132,679,000
2,123,498,000
2,123,953,000
2,029,878,000
2,042,895,000
2,066,007,000
2,131,283,000
2,119,971,000
2,099,368,000
2,156,476,000
2,189,659,000
2,262,061,000
2,272,122,000
2,312,564,000
2,247,801,000
2,223,062,000
1,984,622,000
1,973,880,000
2,103,452,000
2,113,509,000
2,118,880,000
2,096,240,000
2,074,887,000
2,072,807,000
2,093,998,000
2,119,207,000
1,983,442,000
1,973,554,000
1,750,291,000
1,765,368,000
1,697,841,000
1,782,403,000
1,770,230,000
1,726,827,000
1,683,248,000
1,682,492,000
1,680,669,000
1,687,028,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.